Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

NCT00303745 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: irinotecan hydrochloride

Sponsor

Federation Francophone de Cancerologie Digestive